Lupus Research Update:

Research Studies Presented at the ACR Annual Scientific Meeting

Program 2 - Treatments for Lupus

Lupus investigators featured in this video:

	Sandra Navarra, MD Head of Rheumatology University of Santo Tomas, Manila Belimumab, a BLyS-Specific Inhibitor, Reduced Disease Activity, Flares and Prednisone Use in Patients with Active SLE: Efficacy and Safety Results From the Phase 3 BLISS-52 Study		Michele Petri, MD, MPH Director of the Lupus Center Johns Hopkins Medical Institute Four-Year Experience of Belimumab, a BLyS-Specific Inhibitor, in Systemic Lupus Erythematosus (SLE) Patients
	Joan Merrill, MD Member and Program Chair, Clinical Pharmacology Research Program Oklahoma Medical Research Foundation Mycophenolate Mofetil (MMF) Is Effective for Systemic Lupus (SLE) Arthritis, Final Results of An Organ-Specific, Double-Blind, Placebo-Controlled Trial and Treatment of Systemic Lupus Erythematosus (SLE) with Rituximab: 78-Week Safety Data From the Phase II/II EXPLORER Trial		Richard Furie, MD Director of the Novel Therapeutics Program North Shore University Hospital Effect of Rituximab (RTX) On Anti-dsDNA and C3 Levels and Relationship to Response: Results From the LUNAR Trial and Efficacy and Safety of Rituximab in Subjects with Active Proliferative Lupus Nephritis (LN): Results From the Randomized, Double-Blind Phase III LUNAR Study
	Kevin Latinis, MD, PhD Clinical Assistant Professor Kansas University Medical Center Evaluation of CD4+ Lymphopenia and Infection Risk in Systemic Lupus Erythematosus (SLE) Patients: Data From Rituximab Clinical Trials

Additional videos in this series:

Program 1 - About the ACR Meeting
Program 3 - Complications of Lupus
Program 4 - Management of Lupus
Program 5 - Causes and Progression of Lupus
Program 6 - Pregnancy and Lupus

Return to video list

Feel free to share your comments about this series: webmaster@lupus.org

Get your purple lupus awareness wristbands here